We showed that the treatment with OLDA was not able to upregulate the expression of ATF4 compared to vehicle-treated CML cells, highlighting once again that autophagy is not activated (Figure 3C). The gene discussed is ATF4; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.